Jeannelyn S Estrella

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. doi request reprint Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing
    Jeannelyn S Estrella
    Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Mol Cancer Ther 14:2887-95. 2015
  2. doi request reprint Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway
    Jeannelyn S Estrella
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030 Electronic address
    Hum Pathol 45:2051-8. 2014
  3. doi request reprint Ovarian serous carcinoma associated with a distinct "corded and hyalinized" pattern
    Jeannelyn S Estrella
    Departments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Arch Pathol Lab Med 137:275-9. 2013
  4. doi request reprint Mucosal colonization by metastatic carcinoma in the gastrointestinal tract: a potential mimic of primary neoplasia
    Jeannelyn S Estrella
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Am J Surg Pathol 35:563-72. 2011
  5. doi request reprint Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution
    Jeannelyn S Estrella
    Departments of Pathology Gastrointestinal Medical Oncology Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China
    Am J Surg Pathol 38:147-57. 2014
  6. pmc Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation
    Jiansheng Wang
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 118:3801-11. 2012
  7. doi request reprint Hepatobiliary/Pancreas Pathology: SY11-3 PANCREATIC DUCTAL ADENOCARCINOMA: NEOADJUVANT THERAPIES AND PATHOLOGY
    Huamin Wang
    1Department of Pathology 2Department of Surgical Oncology 3Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, USA
    Pathology 46:S25. 2014
  8. pmc Medical management of gastric cancer: a 2014 update
    Elena Elimova
    Elena Elimova, Hironori Shiozaki, Roopma Wadhwa, Kazuki Sudo, Qiongrong Chen, Mariela A Blum, Shumei Song, Jaffer A Ajani, Department of Gastrointestinal Medical Oncology, University of Texas, Anderson Cancer Center, Houston, TX 77030, United States
    World J Gastroenterol 20:13637-47. 2014
  9. pmc Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma
    Deyali Chatterjee
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Histopathology 63:841-51. 2013
  10. doi request reprint Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases
    Hironori Shiozaki
    Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
    J Surg Oncol 113:29-35. 2016

Collaborators

Detail Information

Publications21

  1. doi request reprint Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing
    Jeannelyn S Estrella
    Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Mol Cancer Ther 14:2887-95. 2015
    ..We conclude that VE1 IHC produces suboptimal results in colorectal carcinoma and should not be used to guide patient management. Mol Cancer Ther; 14(12); 2887-95. ©2015 AACR. ..
  2. doi request reprint Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway
    Jeannelyn S Estrella
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030 Electronic address
    Hum Pathol 45:2051-8. 2014
    ..In contrast to sporadic NETs, the occurrence of these lesions in FAP and their high levels of nuclear β-catenin expression support a pathogenic role for the adenomatous polyposis coli/β-catenin pathway. ..
  3. doi request reprint Ovarian serous carcinoma associated with a distinct "corded and hyalinized" pattern
    Jeannelyn S Estrella
    Departments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Arch Pathol Lab Med 137:275-9. 2013
    ..The behavior in this unique case of serous carcinoma associated with a distinct corded and hyalinized pattern was more aggressive than low-grade serous carcinoma, but more favorable than malignant mixed mullerian tumor...
  4. doi request reprint Mucosal colonization by metastatic carcinoma in the gastrointestinal tract: a potential mimic of primary neoplasia
    Jeannelyn S Estrella
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Am J Surg Pathol 35:563-72. 2011
    ..In situ growth and presence of an apparent adenoma cannot be taken as prima facie evidence of a primary neoplasm...
  5. doi request reprint Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution
    Jeannelyn S Estrella
    Departments of Pathology Gastrointestinal Medical Oncology Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China
    Am J Surg Pathol 38:147-57. 2014
    ..001) were important predictors of disease-specific survival in patients with SPN. Our study highlights the importance of pathologic evaluation in risk assessment in patients with SPNs. ..
  6. pmc Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation
    Jiansheng Wang
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 118:3801-11. 2012
    ..However, the prognostic significance of tumor involvement of the resected vein in patients who received neoadjuvant therapy is unclear...
  7. doi request reprint Hepatobiliary/Pancreas Pathology: SY11-3 PANCREATIC DUCTAL ADENOCARCINOMA: NEOADJUVANT THERAPIES AND PATHOLOGY
    Huamin Wang
    1Department of Pathology 2Department of Surgical Oncology 3Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, USA
    Pathology 46:S25. 2014
    ..Therefore careful pathologic evaluation of the pancreatectomy specimens plays a key role in predicting prognosis of patients with PDAC who received NCT and pancreaticoduodenectomy. ..
  8. pmc Medical management of gastric cancer: a 2014 update
    Elena Elimova
    Elena Elimova, Hironori Shiozaki, Roopma Wadhwa, Kazuki Sudo, Qiongrong Chen, Mariela A Blum, Shumei Song, Jaffer A Ajani, Department of Gastrointestinal Medical Oncology, University of Texas, Anderson Cancer Center, Houston, TX 77030, United States
    World J Gastroenterol 20:13637-47. 2014
    ....
  9. pmc Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma
    Deyali Chatterjee
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Histopathology 63:841-51. 2013
    ..To study the histological changes in non-neoplastic pancreas and the effects on pancreatic intraepithelial neoplasia (PanIN) after neoadjuvant chemoradiation therapy (NCRT) for pancreatic ductal adenocarcinoma (PDAC)...
  10. doi request reprint Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases
    Hironori Shiozaki
    Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
    J Surg Oncol 113:29-35. 2016
    ..We compared the overall survival (OS) of patients in 3 groups: those with positive cytology (CY+) by DL (DL-CY+), those with gross PM (GPM) by DL (DL-GPM+) and with GPM obvious on I (I-GPM+)...
  11. doi request reprint Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively
    Nikolaos Charalampakis
    Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Tex, USA
    Oncology 89:305-10. 2015
    ..We used initial standardized uptake value (iSUV) of positron emission tomography (PET) to evaluate its association with overall survival (OS)...
  12. pmc Intrabiliary growth of liver metastases: clinicopathologic features, prevalence, and outcome
    Jeannelyn S Estrella
    Departments of Pathology Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
    Am J Surg Pathol 37:1571-9. 2013
    ..Major duct involvement should be recognized because of its distinctive clinical features, which can overlap with cholangiocarcinoma. ..
  13. doi request reprint Early versus Delayed Therapy of Advanced Gastric Cancer Patients--Does It Make a Difference?
    Elena Elimova
    Department of Gastrointestinal Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Tex, USA
    Oncology 89:215-20. 2015
    ..Therapy is palliative but results in ill effects. The median overall survival (OS) of AGC patients is often <12 months. It is unclear if the early initiation of therapy in all AGC patients is beneficial...
  14. pmc Expression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors: implications for targeted therapy
    Jeannelyn S Estrella
    From the Departments of Pathology, Biostatistics, and Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
    Pancreas 43:996-1002. 2014
    ..The indolent nature and expression of progesterone receptor (PR), a well-known estrogen-induced gene, in a subset of pancreatic neuroendocrine tumors (PanNETs), raise the possibility of hormonal regulation in these tumors...
  15. pmc Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma
    Michael T Tetzlaff
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030
    Hum Pathol 46:1101-10. 2015
    ..Cautious evaluation of heterogeneous BRAF V600E IHC expression is warranted and comparison with sequencing results is critical, given its reduced test specificity and positive predictive value for detecting the BRAF V600E mutation. ..
  16. doi request reprint Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors
    Jeannelyn S Estrella
    From the Departments of Pathology Drs Estrella, Broaddus, Wang, and Rashid, Immunology Ms Mathews, Biostatistics Ms Milton, and Gastrointestinal Medical Oncology, Dr Yao, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Arch Pathol Lab Med 138:1027-36. 2014
    ..In breast and endometrial carcinoma, activation of this pathway inhibits progesterone receptor (PR) expression...
  17. doi request reprint Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation
    Jeannelyn S Estrella
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 118:268-77. 2012
    ..However, analysis of prognostic factors is limited for patients with PDAC treated with neoadjuvant chemoradiation and pancreaticoduodenectomy (PD)...
  18. doi request reprint Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma
    Jeannelyn S Estrella
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
    Am J Surg Pathol 35:1045-53. 2011
    ..EAC invasion into the space between duplicated MM confers a similar risk of lymph node metastasis and recurrence as those of intramucosal EAC, and LVI is the best predictor of lymph node status and RFS in pT1 EAC...
  19. doi request reprint Malignant Solitary Fibrous Tumor of the Pancreas
    Jeannelyn S Estrella
    From the Departments of Pathology, and Diagnostic Radiology, University of Texas M D Anderson Cancer Center, Houston, TX
    Pancreas 44:988-94. 2015
    ..However, given that the presence of a malignant component in extrapancreatic SFT has been associated with recurrence/metastasis and death, complete surgical resection and close long-term follow-up is required. ..
  20. doi request reprint Anti-angiogenic agent ramucirumab: meaningful or marginal?
    Roopma Wadhwa
    Department of GI Medical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd FC10 3022, Houston, TX 77030, USA
    Expert Rev Anticancer Ther 14:367-79. 2014
    ..In this review, we briefly summarize the process of angiogenesis and address the emerging cost-benefit issues that surround all newly developed agents including ramucirumab. ..
  21. doi request reprint Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience
    Akihiro Suzuki
    Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Oncology 82:347-51. 2012
    ..In patients with localized gastric cancer (LGC) who are unfit for surgery, decline surgery, or have unresectable cancer, chemoradiotherapy may provide palliation; however, data in the literature are sparse...